Gregorios A. Paspatis
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Gregorios A. Paspatis has a total of 39 co-authors. Here are the top co-authors by number of shared publications:
E. Vardas
Department of Gastroenterology, Benizelion General Hospital, Heraklion, Crete
8 shared publicationsA. Theodoropoulou
Department of Gastroenterology, Benizelion General Hospital, Heraklion, Crete
7 shared publicationsG. Chlouverakis
Department of Social Medicine, University of Crete, Heraklion, Crete, Greece
7 shared publicationsG. Tribonias
Department of Gastroenterology, Benizelion General Hospital, Heraklion, Crete
6 shared publicationsK. Konstantinidis
Department of Gastroenterology, Benizelion General Hospital, Heraklion, Crete
5 shared publicationsEmmanouil Vardas
4 shared publications
Latest Publications
- 1 April 2013
- Published by Elsevier in Digestive and Liver Disease
- Vol. 45 (4) , 301-304
Sixty- versus thirty-seconds papillary balloon dilation after sphincterotomy for the treatment of large bile duct stones: A randomized controlled trial
- 1 April 2013
- Published by Elsevier in Digestive and Liver Disease
- Vol. 45 (4) , 301-304
Sixty- versus thirty-seconds papillary balloon dilation after sphincterotomy for the treatment of large bile duct stones: A randomized controlled trial
- Open Access
- 21 January 2013
- Published by Springer Nature
Deep sedation compared with moderate sedation in polyp detection during colonoscopy
- 21 January 2013
- Published by Springer Nature
Open AccessDeep sedation compared with moderate sedation in polyp detection during colonoscopy
- Open Access
- 6 December 2012
- Published by Springer Nature
Cold versus hot snare polypectomy in post polypectomy bleeding in small colonic polyps
- 6 December 2012
- Published by Springer Nature
Open AccessCold versus hot snare polypectomy in post polypectomy bleeding in small colonic polyps
- 1 January 2012
- Published by Wolters Kluwer Health in European Journal of Gastroenterology & Hepatology
- Vol. 24 (1) , 102-103
Changing trends in acute upper gastrointestinal bleeding in Crete, Greece
- 1 January 2012
- Published by Wolters Kluwer Health in European Journal of Gastroenterology & Hepatology
- Vol. 24 (1) , 102-103
Changing trends in acute upper gastrointestinal bleeding in Crete, Greece
- 20 September 2011
- Published by Wiley in Colorectal Disease
- Vol. 13 (10) , e345-e348
A prospective randomized comparison of cold vs hot snare polypectomy in the occurrence of postpolypectomy bleeding in small colonic polyps
Polypectomy techniques in the removal of polyps in the 3-8 mm size range are inconsistent. The aim of our study was to compare cold (CSP) with hot snare polypectomy (HSP) in the occurrence of postpolypectomy bleeding in small colonic polyps 3-8 mm in size. In all, 414 consecutive patients with small colorectal polyps 3-8 mm in size were prospectively randomized into the CSP group and the HSP group. There was no early or late postpolypectomy bleeding in either group. Intraprocedural bleeding was significantly more frequent in the CSP group than the HSP group (CSP, 19/208; HSP, 2/206; P<0.001) but resolved spontaneously without any intervention in both groups. The data show that the CSP technique is safe, effective and quicker than HSP for patients and it could be considered the ideal procedure for small polyp removal.
- 20 September 2011
- Published by Wiley in Colorectal Disease
- Vol. 13 (10) , e345-e348
A prospective randomized comparison of cold vs hot snare polypectomy in the occurrence of postpolypectomy bleeding in small colonic polyps
Polypectomy techniques in the removal of polyps in the 3-8 mm size range are inconsistent. The aim of our study was to compare cold (CSP) with hot snare polypectomy (HSP) in the occurrence of postpolypectomy bleeding in small colonic polyps 3-8 mm in size. In all, 414 consecutive patients with small colorectal polyps 3-8 mm in size were prospectively randomized into the CSP group and the HSP group. There was no early or late postpolypectomy bleeding in either group. Intraprocedural bleeding was significantly more frequent in the CSP group than the HSP group (CSP, 19/208; HSP, 2/206; P<0.001) but resolved spontaneously without any intervention in both groups. The data show that the CSP technique is safe, effective and quicker than HSP for patients and it could be considered the ideal procedure for small polyp removal.
- 13 May 2011
- Published by Wiley in Colorectal Disease
- Vol. 13 (6) , e137-e144
Deep sedation compared with moderate sedation in polyp detection during colonoscopy: a randomized controlled trial
Aim The detection rate of adenomas is one of the current quality indicators in high-quality colonoscopy. We compared the performance of colonoscopy for the detection of polyps in patients sedated with deep and moderate sedation. Secondary objectives included the patient's and the endoscopist's satisfaction, recovery time and the adverse events related to sedation between the two groups. Method Five hundred and twenty patients submitted for colonoscopy were prospectively randomized into a deep sedation group (DS group, n = 258) and a moderate sedation (MS group, n = 262) group. In both, sedation and analgesia were performed using midazolam with pethidine. Results There were no differences between the two groups in the following three areas: (1) The overall detection of polyps (DS, 1 [0-20]; MS, 1 [0-15]; P = 0.67), (2): polyp size >= 10 mm (DS, 0.00 [0-7]; MS, 0.00 [0-6]; P = 0.30), and (3) polyp size < 10 mm (DS, 0.00 [0-20]; MS, 0.00 [0-13]; P = 0.83). There was no significant difference in the rate of adenoma detection (DS, 1 [0-10]; MS, 1 [0-9]; P = 0.99). Conclusion The study demonstrated no difference in the detection of polyps by colonoscopy using deep or moderate sedation.
- 13 May 2011
- Published by Wiley in Colorectal Disease
- Vol. 13 (6) , e137-e144
Deep sedation compared with moderate sedation in polyp detection during colonoscopy: a randomized controlled trial
Aim The detection rate of adenomas is one of the current quality indicators in high-quality colonoscopy. We compared the performance of colonoscopy for the detection of polyps in patients sedated with deep and moderate sedation. Secondary objectives included the patient's and the endoscopist's satisfaction, recovery time and the adverse events related to sedation between the two groups. Method Five hundred and twenty patients submitted for colonoscopy were prospectively randomized into a deep sedation group (DS group, n = 258) and a moderate sedation (MS group, n = 262) group. In both, sedation and analgesia were performed using midazolam with pethidine. Results There were no differences between the two groups in the following three areas: (1) The overall detection of polyps (DS, 1 [0-20]; MS, 1 [0-15]; P = 0.67), (2): polyp size >= 10 mm (DS, 0.00 [0-7]; MS, 0.00 [0-6]; P = 0.30), and (3) polyp size < 10 mm (DS, 0.00 [0-20]; MS, 0.00 [0-13]; P = 0.83). There was no significant difference in the rate of adenoma detection (DS, 1 [0-10]; MS, 1 [0-9]; P = 0.99). Conclusion The study demonstrated no difference in the detection of polyps by colonoscopy using deep or moderate sedation.
- Open Access
- 1 January 2011
- Published by Baishideng Publishing Group Inc. in World Journal of Gastrointestinal Endoscopy
- Vol. 3 (2) , 34-39
Deep sedation for endoscopic retrograde cholangiopacreatography
Deep sedation for endoscopic retrograde cholangiopacreatography
- 1 January 2011
- Published by Baishideng Publishing Group Inc. in World Journal of Gastrointestinal Endoscopy
- Vol. 3 (2) , 34-39
Open AccessDeep sedation for endoscopic retrograde cholangiopacreatography
Deep sedation for endoscopic retrograde cholangiopacreatography
- Open Access
- 1 April 2010
- Published by S. Karger AG in Digestion
- Vol. 82 (2) , 84-86
Level of Intended Sedation
Sedation and analgesia is the standard of care during diagnostic and therapeutic endoscopic gastrointestinal procedures in most areas of the world. Unsedated endoscopy is feasible in selected patients, but requires commitment on the part of both the patient and the provider. The American Society of Anesthesiologists has defined four stages of sedation, ranging from minimal to moderate, deep and general anesthesia. The level of sedation as well as the choice of sedative is based on the type of procedure, patient characteristics and the existence of the required structural conditions. Individuals administering sedation/analgesia should be trained to rescue a patient who has reached a level of sedation deeper than that intended.
- 1 April 2010
- Published by S. Karger AG in Digestion
- Vol. 82 (2) , 84-86
Open AccessLevel of Intended Sedation
Sedation and analgesia is the standard of care during diagnostic and therapeutic endoscopic gastrointestinal procedures in most areas of the world. Unsedated endoscopy is feasible in selected patients, but requires commitment on the part of both the patient and the provider. The American Society of Anesthesiologists has defined four stages of sedation, ranging from minimal to moderate, deep and general anesthesia. The level of sedation as well as the choice of sedative is based on the type of procedure, patient characteristics and the existence of the required structural conditions. Individuals administering sedation/analgesia should be trained to rescue a patient who has reached a level of sedation deeper than that intended.
- 4 December 2009
- Published by Georg Thieme Verlag KG in Endoscopy
- Vol. 41 (12) , 1046-1051
Efficacy of bispectral index monitoring as an adjunct to propofol deep sedation for ERCP: a randomized controlled trial
Background and study aims: We sought to determine whether bispectral index (BIS) monitoring is a useful adjunct to the administration of propofol titrated to deep sedation, as measured by reductions of doses of propofol administered during endoscopic retrograde cholangiopancreatography (ERCP). Patients and methods: 90 consecutive patients undergoing ERCP were randomized to receive propofol titrated to deep sedation, with the BIS value either visible (BIS group, n = 46) or invisible (control group, n = 44) to the anesthesiologist. In the BIS group, the anesthesiologist was instructed to use the BIS value as the primary end point for titration of sedation, and to target BIS values between 40 and 60. For the control group, the anesthesiologist was instructed to titrate propofol according to routine practice in the unit using the modified Observer’s Assessment of Alertness/Sedation (MOAA/S) Scale (MOAA/S score 0). Results: The mean (SD) propofol doses (mg/min per kg weight) were 0.139 (0.02) and 0.193 (0.02) for the BIS and control groups, respectively (P < 0.001). Mean (SD) BIS values throughout the procedure were 61.68 (7.5) and 56.93 (4.77) for the BIS and control groups, respectively (P = 0.001). During the maintenance phase of sedation (MOAA/S score 0), the mean (SD) BIS values were 53.73 (8.67) and 45.65 (4.39) for the BIS and control groups, respectively (P < 0.001). Conclusions: Our data suggest that BIS monitoring led to a reduction in the mean propofol dose when the BIS value was used as the primary target for sedation in ERCP procedures.
- 4 December 2009
- Published by Georg Thieme Verlag KG in Endoscopy
- Vol. 41 (12) , 1046-1051
Efficacy of bispectral index monitoring as an adjunct to propofol deep sedation for ERCP: a randomized controlled trial
Background and study aims: We sought to determine whether bispectral index (BIS) monitoring is a useful adjunct to the administration of propofol titrated to deep sedation, as measured by reductions of doses of propofol administered during endoscopic retrograde cholangiopancreatography (ERCP). Patients and methods: 90 consecutive patients undergoing ERCP were randomized to receive propofol titrated to deep sedation, with the BIS value either visible (BIS group, n = 46) or invisible (control group, n = 44) to the anesthesiologist. In the BIS group, the anesthesiologist was instructed to use the BIS value as the primary end point for titration of sedation, and to target BIS values between 40 and 60. For the control group, the anesthesiologist was instructed to titrate propofol according to routine practice in the unit using the modified Observer’s Assessment of Alertness/Sedation (MOAA/S) Scale (MOAA/S score 0). Results: The mean (SD) propofol doses (mg/min per kg weight) were 0.139 (0.02) and 0.193 (0.02) for the BIS and control groups, respectively (P < 0.001). Mean (SD) BIS values throughout the procedure were 61.68 (7.5) and 56.93 (4.77) for the BIS and control groups, respectively (P = 0.001). During the maintenance phase of sedation (MOAA/S score 0), the mean (SD) BIS values were 53.73 (8.67) and 45.65 (4.39) for the BIS and control groups, respectively (P < 0.001). Conclusions: Our data suggest that BIS monitoring led to a reduction in the mean propofol dose when the BIS value was used as the primary target for sedation in ERCP procedures.
- 23 November 2009
- Published by Wiley in Colorectal Disease
- Vol. 12 (10Online) , e260-6
Comparison of standard vs high‐definition, wide‐angle colonoscopy for polyp detection: a randomized controlled trial
Aim We sought to compare the performance of colonoscopy using a high‐definition, wide‐angle endoscope vs a standard colonoscope for the detection of polyps. Method A total of 390 patients were prospectively randomized into high‐definition colonoscopy group (HD, n = 193) and standard colonoscopy group (SC, n = 197). Results Analysis demonstrated that there were significant differences between the two groups, as far as the overall rate of polyps (SC, 1.31 ± 1.90; HD, 1.76 ± 2.31; P = 0.03) and the rate of small hyperplastic polyps (size < 5 mm; SC, 0.10 ± 0.36; HD, 0.25 ± 0.61; P = 0.003) were concerned. No significant differences between the two groups were observed, regarding large polyps (size ≥ 10 mm; SC, 0.39 ± 0.89; HD, 0.48 ± 0.80; P = 0.10), medium polyps (10 mm > size ≥ 5 mm; SC, 0.60 ± 1.46; HD, 0.58 ± 1.25; P = 0.31) and small polyps (size < 5 mm; SC, 0.32 ± 0.86; HD, 0.71 ± 1.65; P = 0.09). Similarly, no significant differences were demonstrated in the detection rate of adenomas and hyperplastic polyps, large adenomas, medium adenomas, small adenomas and large and medium hyperplastic polyps. Conclusion High‐definition colonoscopy led to a significant increase in the polyp detection.
- 23 November 2009
- Published by Wiley in Colorectal Disease
- Vol. 12 (10Online) , e260-6
Comparison of standard vs high‐definition, wide‐angle colonoscopy for polyp detection: a randomized controlled trial
Aim We sought to compare the performance of colonoscopy using a high‐definition, wide‐angle endoscope vs a standard colonoscope for the detection of polyps. Method A total of 390 patients were prospectively randomized into high‐definition colonoscopy group (HD, n = 193) and standard colonoscopy group (SC, n = 197). Results Analysis demonstrated that there were significant differences between the two groups, as far as the overall rate of polyps (SC, 1.31 ± 1.90; HD, 1.76 ± 2.31; P = 0.03) and the rate of small hyperplastic polyps (size < 5 mm; SC, 0.10 ± 0.36; HD, 0.25 ± 0.61; P = 0.003) were concerned. No significant differences between the two groups were observed, regarding large polyps (size ≥ 10 mm; SC, 0.39 ± 0.89; HD, 0.48 ± 0.80; P = 0.10), medium polyps (10 mm > size ≥ 5 mm; SC, 0.60 ± 1.46; HD, 0.58 ± 1.25; P = 0.31) and small polyps (size < 5 mm; SC, 0.32 ± 0.86; HD, 0.71 ± 1.65; P = 0.09). Similarly, no significant differences were demonstrated in the detection rate of adenomas and hyperplastic polyps, large adenomas, medium adenomas, small adenomas and large and medium hyperplastic polyps. Conclusion High‐definition colonoscopy led to a significant increase in the polyp detection.